Skip to main content
. 2019 Jul 29;9:10898. doi: 10.1038/s41598-019-45319-4

Figure 5.

Figure 5

Antibodies-added (Combined) IF expression of pho-4EBP1 and pho-S6K1 for both the control group and the 500 nM everolimus group after 24 hours. (a) Everolimus-sensitive cells (Hs578T, MCF7 cell lines). (b) Everolimus-resistant cells (MDA-MB-231, BT474 cell lines and ABC-16TX1 PDCC).